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The telomeric CTC1/STN1/TEN1 (CST) complex has
been implicated in promoting replication recovery
under replication stress at genomic regions, yet its
precise role is unclear. Here, we report that STN1 is
enriched at GC-rich repetitive sequences genome-
wide in response to hydroxyurea (HU)-induced repli-
cation stress. STN1 deficiency exacerbates the
fragility of these sequences under replication stress,
resulting in chromosome fragmentation. We find
that upon fork stalling, CST proteins form distinct nu-
clear foci that colocalize with RAD51. Furthermore,
replication stress induces physical association of
CSTwith RAD51 in an ATR-dependentmanner. Strik-
ingly, CST deficiency diminishes HU-induced RAD51
foci formation and reduces RAD51 recruitment to
telomeres and non-telomeric GC-rich fragile se-
quences. Collectively, our findings establish that
CST promotes RAD51 recruitment to GC-rich repeti-
tive sequences in response to replication stress to
facilitate replication restart, thereby providing in-
sights into the mechanism underlying genome sta-
bility maintenance.
INTRODUCTION
Faithful and complete duplication of chromosomal DNA is
vital for avoiding detrimental replication errors and preserving
genome stability. Replication stress, induced by exposure to
environmental agents, oncogenic stress, or partial inhibition of
DNA replication, results in fork stalling at fragile sites (FSs) that
may lead to fork collapse, thereby generating DNA breaks that
trigger unwanted repair or rearrangement activities and driving
genome instability (Debacker and Kooy, 2007; Debatisse et al.,
2012; Durkin and Glover, 2007; Tercero et al., 2003). FSs
are frequently involved in sister chromatid exchanges, dele-
tions, translocations, and intra-chromosomal gene amplifica-1300 Cell Reports 16, 1300–1314, August 2, 2016 ª 2016 The Author
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certain tumor suppressors, have been identified within FSs
(Arlt et al., 2006; Barlow et al., 2013; Debacker and Kooy,
2007; Durkin and Glover, 2007; Ozeri-Galai et al., 2012). There-
fore, pathways have evolved to prevent fork stalling and to
facilitate the restart of stalled replication to preserve genome
stability.
Successful rescue of stalled replication requires coordination
of multiple proteins that stabilize stalled forks and promote rein-
itiation of DNA synthesis (Franchitto and Pichierri, 2014; Zeman
and Cimprich, 2014). Crucial genome maintenance proteins,
including RAD51, MRE11, XRCC3, SLX1-SLX4-MUS81-EME1,
BLM, WRN, RTEL1, SMARCAL1, and FANCD2, play important
roles in this process (Be´tous et al., 2012; Bryant et al., 2009; Da-
vies et al., 2007; Franchitto and Pichierri, 2004; Hanada et al.,
2007; Hashimoto et al., 2010; Pepe and West, 2014; Petermann
and Helleday, 2010; Petermann et al., 2010; Sarbajna et al.,
2014; Schlacher et al., 2012; Sidorova et al., 2008; Tittel-Elmer
et al., 2009; Vannier et al., 2013). In addition, TIMELESS, TIPIN,
CLASPIN, and AND1 form the replication protection complex
that stabilizes stalled forks and keeps helicases connected to
polymerases, thus preventing excessive DNA unwinding (Chini
and Chen, 2003, 2004; Errico et al., 2007, 2009; Gotter et al.,
2007; Kemp et al., 2010; Kumagai and Dunphy, 2000; Lee
et al., 2003; Unsal-Kac¸maz et al., 2007; Zhu et al., 2007). Fork
restart also requires reinitiation of DNA synthesis mediated by
various replication factors, including MCM2-7, PCNA, CDC45,
and POLd (Heller and Marians, 2006), and the PrimPol primase
that is important for priming DNA synthesis at stalled forks (Bian-
chi et al., 2013; Garcı´a-Go´mez et al., 2013; Mouro´n et al., 2013).
The human CST complex (hCST), composed of the three pro-
teins CTC1, STN1, and TEN1, has emerged as an important
player in counteracting replication stress. CST is an RPA-like
complex that binds non-specifically to single-stranded DNA
(ssDNA) with high affinity (Miyake et al., 2009). Originally discov-
ered as a telomere maintenance factor (described later), the
hCST complex also promotes efficient replication of difficult-
to-replicate sequences in the genome (Kasbek et al., 2013;
Stewart et al., 2012). Deficiency in CST components reduces
cell viability after exposure to reagents stalling replication forks,(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
including hydroxyurea (HU), aphidicolin (APH), methyl methane-
sulfonate (MMS), and camptothecin (Wang et al., 2014; Zhou and
Chai, 2016). Mutations in CTC1 cause Coats plus disease, a
complex disorder characterized by bilateral exudative retinop-
athy, retinal telangiectasias, growth retardation, intracranial cal-
cifications, bone abnormalities, and gastrointestinal vascular
ectasias, accompanied by common early-aging pathological
features such as premature hair graying, anemia, and osteopo-
rosis (Anderson et al., 2012; Armanios and Blackburn, 2012;
Keller et al., 2012; Polvi et al., 2012). DNA fiber analysis shows
that STN1 suppression decreases new origin firing following
release from HU (Stewart et al., 2012), while other studies
show that CST stimulates the priming activity of DNA polymer-
ase a-primase (POLa) and primase-to-polymerase switching
in vitro and increases the affinity of POLa for template DNA (Cas-
teel et al., 2009; Lue et al., 2014; Nakaoka et al., 2012). However,
evidence supporting the involvement of CST’s stimulatory effect
on POLa in replication restart is lacking. The molecular mecha-
nism underlying how CST facilitates replication restart at non-te-
lomeric sites remains largely unknown; moreover, the interplay
between CST and other key replication restart players remains
unexplored.
The role of CST in telomere maintenance is better defined. The
hCST complex interacts with the TPP1-POT1 shelterin complex
(Chen et al., 2012; Wan et al., 2009). Mammalian CST promotes
efficient replication of telomeric DNA, mediates C strand syn-
thesis at telomere ends during late S/G2 phase, and inhibits telo-
merase access to telomeres to prevent excessive telomere
lengthening (Chen et al., 2012; Huang et al., 2012; Kasbek
et al., 2013; Stewart et al., 2012; Wang et al., 2014). A subset
of CTC1 mutations identified in Coats plus patients induces
accelerated telomere shortening and displays telomeric DNA
replication defects (Anderson et al., 2012; Chen et al., 2013;
Gu and Chang, 2013), leading to the conclusion that the path-
ogenesis of Coats plus may partly derive from telomere
maintenance defects. CST-related proteins are also present
in Saccharomyces cerevisiae, Schizosaccharomyces pombe,
Tetrahymena thermophila, and Arabidopsis thaliana (Gao et al.,
2007; Martı´n et al., 2007; Surovtseva et al., 2009; Wan et al.,
2015). In budding yeast, the Cdc13-Stn1-Ten1 complex controls
telomerase access to telomeres and is an essential component
for capping telomere ends that protect the C strand from degra-
dation (reviewed in Giraud-Panis et al., 2010, and references
therein). CST proteins in fission yeast and plants are also
required for telomere capping (Martı´n et al., 2007; Song et al.,
2008; Surovtseva et al., 2009), while human and mammalian
CST lack the capping function (Boccardi et al., 2015; Gu et al.,
2012; Huang et al., 2012). It appears that the telomere capping
function of CST in yeasts and plants has been lost during evolu-
tion, but its functions in telomere replication and C strand syn-
thesis have been preserved (Price et al., 2010).
Each CST subunit contains the oligonucleotide- or oligosac-
charide-binding (OB)-fold domains formed by five-stranded
beta-barrel motifs. The OB-fold domains are known to be
frequently used in binding to ssDNA or single-stranded RNA
and in mediating protein-protein interactions (Arcus, 2002; Flynn
and Zou, 2010; Theobald et al., 2003). STN1 and TEN1 structures
are highly conserved from yeast to humans, with conformationalsimilarities to the two smaller subunits of the RPA complex
RPA32 and RPA14 (Bryan et al., 2013; Sun et al., 2009; Wan
et al., 2015). TEN1, the smallest subunit, contains a single OB
fold that interacts with the N-terminal portion of STN1. Human
STN1 contains an OB-fold domain in the N terminus and two
wing-helix-turn-helix (wHTH) motifs at the C terminus (Bryan
et al., 2013), and both domains are required for CTC1 and
TEN1 interaction (Miyake et al., 2009). Although the structure
of the largest subunit CTC1 is unavailable, its predicted structure
contains multiple putative OB-fold domains, with the C-terminal
OB fold interacting with STN1-TEN1 (Chen et al., 2013; Miyake
et al., 2009). The hCST complex efficiently binds to 32 nt or
longer single-strand oligonucleotides containing a variety of G-
or C-rich sequences with high affinity (Miyake et al., 2009). Unlike
the Cdc13-Stn1-Ten1 complex in budding yeast, which binds
specifically to telomeric DNA with subnanomolar affinity (Nugent
et al., 1996), hCST lacks sequence specificity. Although hCST
preferentially binds to G-rich versus C-rich oligonucleotides,
such preferred binding disappears as oligonucleotide lengths in-
crease (Chen et al., 2012). In vitro binding assays reveal that the
C-terminal half of CTC1 is important for DNA binding, whereas
both the N and the C termini of CTC1 are required for telomeric
DNA binding in vivo, suggesting that telomeric association of
CST relies on DNA binding, complex formation, and interaction
with POLa (Chen et al., 2013).
In this study, we investigate the molecular mechanism by
whichCST promotes the restart of stalled replication.We employ
chromatin immunoprecipitation sequencing (ChIP-seq) to map
STN1-binding sites in the human genome under HU-induced
replication stress. We find that STN1 is significantly enriched at
GC-rich repetitive sequences genome-wide after fork stalling.
Fluorescence in situ hybridization (FISH) analysis reveals that
these STN1-binding sites are prone to breakage under replica-
tion stress, and STN1 deficiency further elevates the frequency
of instabilities at these sites, resulting in chromosome fragmen-
tation. Next, we show that upon exposure to HU, CST proteins
form distinct nuclear foci that colocalize with RAD51. In addition,
replication stress markedly induces physical interaction of CST
proteins with RAD51 in a DNA-independent manner, and the
CST/RAD51 interaction depends on ATR. We observe that sup-
pression of each CST protein drastically impairs HU-induced
RAD51 foci formation. Furthermore, ChIP assays show that
STN1 suppression reduces RAD51 recruitment to telomeres
and non-telomeric GC-rich sequences. Collectively, our findings
establish that CST is an important component for maintaining
the stability of GC-rich repetitive sequences genome-wide in
response to replication stress. We propose that CST facilitates
RAD51 recruitment to these sequences when replication forks
stall, promoting efficient replication restart and suppressing
genome instability under replication stress.
RESULTS
STN1 Is Enriched at Telomeric and Non-telomeric GC-
Rich Repetitive Sequences Genome-wide in Response
to Replication Stress
Analysis of gene expression data from several databanks (Onco-
mine, 2012) reveals that human STN1 expression is universallyCell Reports 16, 1300–1314, August 2, 2016 1301
suppressed in multiple types of tumors, including colorectal,
esophageal, breast, lung, cervical, brain, prostate, gastric, and
head and neck cancers (Figure S1; Table S1). The reduced
STN1 expression in tumor tissues suggests that STN1 may be
important in tumor suppression. It has been shown that STN1
deficiency induces g-H2AX-labeled DNA damage at non-telo-
meric sites (Huang et al., 2012) and CST promotes efficient repli-
cation restart after fork stalling (Stewart et al., 2012). Thus, we
hypothesized that CSTmight play an important role in protecting
the stability of difficult-to-replicate sequences in the genome
under replication stress. To understand the nature of these se-
quences, we employed ChIP-seq to determine the STN1-bind-
ing sites genome-wide under replication stress. To overcome
the unavailability of ChIP-quality STN1 antibody, we constructed
HeLa cells stably expressing Myc-STN1 (HeLa-Myc-STN1) with
retroviral transduction.Western blotting showed that the expres-
sion level of exogenous Myc-STN1 was comparable to that of
endogenous STN1 (Figure 1A), minimizing possible artifacts
induced by protein overexpression. We also noticed that ex-
pressing exogenous Myc-STN1 suppressed endogenous STN1
expression (Figure 1A), indicating that STN1 expression is likely
regulated by a negative feedback mechanism.
HeLa-Myc-STN1 was then synchronized in a G1/S phase
boundary with a double-thymidine block, released into S
phase for 3 hr, and then treated with 2 mM HU for 3 hr to
induce replication stress. Subsequently, ChIP assays were
performed with anti-myc antibody (Figure 1B). Fluorescence-
activated cell sorting (FACS) analysis showed that HU treat-
ment significantly stalled replication progression, and most
cells remained in mid-S phase (Figure 1C). To minimize
possible effects caused by different cell-cycle stages, cells
synchronized in mid-S phase (3 hr after double-thymidine
release) were used as control in ChIP assays. Following
ChIP, STN1-binding DNA was subjected either to slot blot
to detect STN1 binding to telomeres or to Illumina Hi-Seq
2500 next-generation sequencing to detect its binding sites
genome-wide.
Under unstressed conditions, components of the CST com-
plex are associated with telomeres, which are naturally occurring
FSs. However, such an association is weak in S phase, and telo-
meric association of CST is strongest in late S/G2 phase (Chen
et al., 2012; Miyake et al., 2009). We confirmed the weak associ-
ation of STN1 with telomeres in mid-S phase (Figure 1D). Upon
HU treatment, STN1 association with telomeres increased (Fig-
ure 1D), suggesting additional STN1 recruitment to telomeres
in response to replication stress.
Two independent HU treatments and ChIP-seq were per-
formed, giving rise to 3,430 and 2,988 significant ChIP-seq peaks
(p < 0.001), respectively. The two experiments showed high
reproducibility of genome-wide STN1 association in response
to HU, with Spearman correlation coefficient R2 = 0.9852, sug-
gesting a high confidence of ChIP-seq data. Snapshots of
ChIP-seq peaks at various loci, including STN1-binding and
non-binding sites, are shown in Figure 1E. To validate ChIP-seq
results, we performed an independent ChIP assay followed by
PCR to detect STN1 binding to representative non-telomeric
sequences identified from ChIP-seq. Five ChIP-seq loci were
analyzed. Upon HU treatment, STN1 was enriched at four of1302 Cell Reports 16, 1300–1314, August 2, 2016these sites but not at tubulin, GAPDH, or the SLITRK6 loci that
were not identified by ChIP-seq (Figure S3), validating our
ChIP-seq results. One ChIP-seq locus showed amplification
in both Myc-vector-only control and Myc-STN1 ChIP, suggest-
ing that a small portion of peaks might have resulted from
non-specific binding of myc antibody during the ChIP-seq
experiment.
Analysis of ChIP-seq reads revealed that STN1 was enriched
at repetitive sequences, with nearly 90% of sequences contain-
ing repetitive features (Figure 2A). These repetitive sequences
included long interspersed nuclear elements (LINEs) and short
interspersed nuclear elements (SINEs), as well as regions of
low complexity (>100 nt stretch of >87% AT or 89% GC, and
>30 nt stretch with >29 nt poly(N)n, where N denotes any nucle-
otide) and those containing simple repeats (short tandem
repeats like (50-TTAGGG-30)n) (Figure 2A). STN1-binding sites
also displayed higher G and C contents than chromosomal aver-
ages by 8% GC (p = 1.14e287,300, chi-square test) (Fig-
ure 2B). Many sequences contain G-rich repeats. Examples of
STN1-binding sequences containing G-rich repeats are shown
in Figure 2C and Figure S4. We also recovered telomeric se-
quences (sequencing reads with R12 tandem 50-TTAGGG-30
repeats) from unaligned sequences, confirming STN1 binding
to telomeres. Interestingly, 1.3% of non-telomeric sequencing
reads contained a 50-TTAGGG-30 sequence or sequences, with
most of these reads (98%) containing a single 50-TTAGGG-30
sequence in isolation and/or non-tandem 50-TTAGGG-30 re-
peats, corroborating the previously identified lack of sequence
specificity of hCST (Miyake et al., 2009). After aligning se-
quencing peaks to the reference genome, we found that a great
portion (73%) of peaks resided within known or predicted
CpG islands (epigenetic score R 0.5, p = 1.72e2017409,
chi-square test) (Figure 2D). Altogether, our data suggest that
STN1 is preferentially localized at GC-rich repetitive sequences
genome-wide.
STN1-Binding Sites Exhibit Fragility upon Exposure to
Replication Stress
The sequence features of STN1-binding sites, including high GC
contents, repetitiveness, and CpG dinucleotides, share similar-
ities with early-replicating fragile sites (ERFSs) identified in
mouse B lymphocytes (Barlow et al., 2013). We therefore exam-
ined the stability of STN1-binding sequences under replication
stress. STN1 was knocked down with two short hairpin RNA
(shRNA) sequences (Figure 3A), cells were treated with HU
(2 mM), and FISH was performed on chromosome spreads to
detect fragility of these sequences. Four representative sites
were examined (HU-8, HU-9, HU-10, and HU-12), as well as
two non-STN1-binding control sites (ACTIN and SLITRK6). In
the absence of replication stress, the FISH signal at individual
chromatids is normally represented as a single signal with an
intensity that is roughly equal to that at the sister chromatid
(Figure 3B). After HU exposure, increased fragility was observed
at all four sites, characterized by increased DNA breakage,
abnormal signal elongation, bridges, and signals spatially sepa-
rated from the chromosome (Figure 3B). STN1 deficiency further
elevated fragility of these sites (Figure 3C). In some cases, one
chromatid arm was severed at the hybridization point and lost
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Figure 1. Enrichment of STN1 at Telomeres and Non-telomeric Sequences in Response to Replication Stress
(A) Myc-STN1 was expressed in HeLa cells at a near endogenous level using retroviral transduction. STN1 expression was detected by western blotting with anti-
STN1 or anti-myc antibody. Exogenous (exo) Myc-STN1 was expressed at a similar level to endogenous (endo) STN1. Expression of exo Myc-STN1 also
suppressed endo STN1 expression. HeLa pBp, HeLa cells expressing pBabe-puro vector.
(B) Experimental plan of sample preparation for ChIP experiments. HeLa-Myc-STN1 cells were synchronized with a double-thymidine block, released into
S phase for 3 hr, and then treated with HU (2 mM) for 3 hr, followed by crosslinking. ChIP DNA was used both for slot blot to detect STN1-bound telomeric DNA
and for Illumina sequencing.
(C) FACS analysis of DNA content of DMSO- and HU-treated cells. Untreated sample 3 hr after double-thymidine release was used as control in ChIP assays.
(D) ChIP of Myc-STN1 binding to telomeric DNA after fork stalling. ChIP DNA was loaded onto slot blot, and telomeric DNA was detected by hybridization with a
32P-(50-TTAGGG-30 )3 probe. Themembranewas then stripped and rehybridized to Alu repeat probe. Lastly, themembranewas stripped again and hybridized to a
probe recognizing a b-actin sequence. Quantification of ChIP results was from three independent ChIP experiments. The p value was calculated with two-tailed
t test. Error bars, SEM.
(E) Genome browser tracks of three STN1-binding sites, HU-8, HU-9, and HU-12, and non-binding site SLITRK6 in two ChIP-seq replicates. CpG islands are
labeled with green bars below the tracks.(Figure 3B; HU-9, white circle indicating the missing chromatid
arm). Control probes exhibited minimal fragility, regardless of
STN1 depletion and replication stress (Figure 3C). Concurrently,
we observed a marked increase of chromosome fragmentation
in HU-treated STN1-deficient cells, suggesting a high level of
chromosome instability (Figures 3D and 3E). Our results support
that STN1-binding sites identified from ChIP-seq are likely bonafide FSs that are sensitive to replication stress and that functional
STN1 is required for protecting the stability of these loci and
chromosome integrity under replication stress.
Given that several STN1-binding sites were fragile after HU
treatment (Figure 3), we analyzed whether STN1 might be
enriched at known FSs that are prone to break upon replication
stress. Human common fragile sites (CFSs) induced by lowCell Reports 16, 1300–1314, August 2, 2016 1303
Figure 2. Mapping STN1-Binding Sites Genome-wide upon HU Exposure
(A) Relative frequency of repetitive sequences among STN1-binding sites. Repetitive sequences were identified using RepeatMasker. LTR, long terminal repeat;
DNA, repetitive transposable element; Simple, short tandem repeat; Low complexity, low-complexity repeat; RNA, RNA repeat, including RNA, tRNA, rRNA,
small nuclear RNA, small cytoplasmic RNA, and signal recognition particle RNA.
(B) STN1-binding sequences contain higher G and C nucleotide content compared to the average of GC content of each human chromosome.
(C) One example of GC-rich repetitive genomic sequences identified from STN1 ChIP-seq. Gs and Cs are indicated in bold. Continuous Gs or Cs with at least 4 nt
in length are underlined. CpG islands are in yellow. 50-TTAGGG-30 and variants of 50-TTAGGG-30 sequences are in green.
(D) Proportion of STN1-binding sites containing CpG islands.doses of APH or oncogene expression have been defined cyto-
genetically in lymphocytes, fibroblasts, colon epithelial cells, and
erythroid cells (Hosseini et al., 2013; Le Tallec et al., 2011, 2013;
Miron et al., 2015). These sites are usually megabase-long chro-
mosomal regions and associated with large genes (Helmrich
et al., 2011), with CFS fragility being tissue dependent (Letessier
et al., 2011). BecauseCFSs have not beenmapped in HeLa cells,
we used a group of 111 reported human CFS sequences identi-
fied in other cell types (Durkin and Glover, 2007; Fungtammasan
et al., 2012; Schwartz et al., 2006) as putative CFSs in HeLa.
Aligning STN1 ChIP-seq peaks to the genome revealed that
only a portion of STN1-binding peaks (25%) overlapped with
or were located near these putative CFSs (Figure S5). Despite
ChIP-seq peaks mapping to CFSs at a greater frequency than
expected for a random distribution (p = 0.017, chi-square test),
a large portion of peaks resided outside putative CFSs (Fig-1304 Cell Reports 16, 1300–1314, August 2, 2016ure S5). In addition, sequences used in Figure 3 (HU-8, HU-9,
HU-10, and HU-12) that displayed fragility upon replication
stress were all located outside these putative CFSs. Thus, it is
likely that STN1 may protect the stability of a group of non-
CFS sequences that are sensitive to HU-induced replication
stress.
Replication Stress Induces CST Proteins to Form
Distinct Foci that Partially Colocalize with RAD51
Because STN1 depletion increased fragility of its binding se-
quences under HU (Figure 3), we hypothesized that CST might
be at stalled forks to promote replication restart. RAD51 is the
key player that localizes at stalled forks and is required for stabi-
lizing stalled forks and restarting replication (Arlt et al., 2006; Ha-
shimoto et al., 2010; Petermann and Helleday, 2010; Petermann
et al., 2010). Upon replication stress, RAD51 forms foci at stalled
(legend on next page)
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forks. We then examined whether CST colocalized with RAD51
after stress. We constructed HeLa cells stably expressing
FLAG-STN1 (HeLa-FLAG-STN1) using retroviral transduction.
As shown in Figure 4A, STN1 showed weak and dispersed
nuclear staining without replication stress. In striking contrast,
it formed distinct foci following HU exposure (Figure 4A). Simul-
taneously, increased colocalization of FLAG-STN1 foci with
RAD51 was observed (Figures 4B and 4C), suggesting that
STN1 also localized at stalled sites. Not all STN1 foci colocalized
with RAD51 in a given cell, indicating that STN1 may be involved
in RAD51 independent pathways to facilitate the reinitiation of
stalled replication.
Because two distinct pathways are used for restarting stalled
forks in response to short and prolonged HU treatment (Peter-
mann et al., 2010), we compared STN1/RAD51 colocalization
in cells exposed to HU for a short time (3 hr) and a prolonged
time (20 hr). Both treatments showed nearly identical STN1/
RAD51 colocalization patterns (Figure S6), indicating that STN1
colocalizes with RAD51 regardless of HU treatment time and
perhaps participates in replication restart in both pathways
involving RAD51.
Next, we constructed HeLa cells stably expressing hemagglu-
tinin (HA)-tagged TEN1 (HeLa-HA-TEN1) or Myc-tagged CTC1
(HeLa-Myc-CTC1) with retroviral transduction and exposed cells
to HU overnight. Like STN1, TEN1 and CTC1 showed weak nu-
clear staining in the absence of replication stress (Figures 4D and
4G). Following HU treatment, both proteins formed distinct foci
(Figures 4D and 4G). Similar to STN1, a significant portion of
TEN1 and CTC1 foci colocalized with RAD51 (Figures 4D–4I).
Altogether, our results suggest that CST proteins localize at
stalled forks.
Replication Stress Induces Physical Interaction
between CST and RAD51 in an ATR-Dependent Manner
In addition to CST/RAD51 colocalization, we observed physical
interaction between CST proteins and RAD51 under replica-
tion stress. In coimmunoprecipitation (coIP) assays, HeLa-
Myc-STN1 cells were treated for 24 hr with HU (2 mM) or APH
(0.2 mM) and then subjected to coIP with anti-myc antibody. As-
sociation between STN1 and endogenous RAD51 was detected
in HU- or APH-treated cells, while such association was negli-
gibly detectable in unstressed cells (Figure 5A). This explains
why CST/RAD51 interaction was not observed previously under
the unstressed condition (Miyake et al., 2009). Reciprocal coIP
confirmed STN1/RAD51 interaction in cells treated with HU or
APH (Figure 5B). The STN1/RAD51 interaction was likely notFigure 3. Fragility of STN1-Binding Sequences in the Presence of HU
(A) Western blot showing STN1 knockdown with two independent shRNA seque
(B) Examples of aberrant structures at STN1-binding loci HU-8, HU-9, HU-10, and
of HU-8, HU-9, HU-10, and HU-12 on individual chromosomes are indicated as re
White arrows, FS breakage; white circle, missing chromosome arm; yellow arro
necting to each other; green arrows, missing signals; blue arrows, signals spatia
(C) Quantification of frequency of abnormalities at each locus in untreated and HU
negative controls. GC content for each locus is indicated. N denotes the numbe
(D) Representative images showing chromosome fragmentation in STN1 knockd
(E) Percentage of metaphase spreads with chromosome fragmentation. Here n
Binomial z statistic pairwise comparison was used to calculate statistical signific
*p% 0.05, **p% 0.01, ***p% 0.001.
1306 Cell Reports 16, 1300–1314, August 2, 2016mediated by DNA, because STN1/RAD51 association remained
unchanged after DNase I treatment (Figure 5C).
Similarly, CTC1 and TEN1 physically interacted with RAD51 in
response to HU or APH treatment, while such interaction was
minimal without replication stress (Figures 5D–5F). Immunopre-
cipitation (IP) of endogenous RAD51 pulled down all three com-
ponents ofCSTafterHUorAPHexposure (Figure 5D). Reciprocal
coIP confirmed CTC1/RAD51 and TEN1/RAD51 interaction in
cells treatedwithHUorAPH (Figures5Eand5F).HUorAPH treat-
ment did not affect CST complex formation, because FLAG-
CTC1 efficiently pulled down bothMyc-STN1 andHA-TEN1 after
HUorAPH treatment (Figure 5E). Collectively, our results suggest
that in response to HU or APH treatment, the CST complex and
RAD51 are in proximity and likely in the same complex, further
supporting that CST is localized at stalled forks.
ATR is themajor kinase in response to replication stress (Flynn
and Zou, 2011). Our results showed that CST/RAD51 interaction
were drastically diminished upon ATR inhibition (Figure 5G).
Thus, CST/RAD51 interaction is likely regulated by the ATR
signaling pathway.
CST Deficiency Reduces RAD51 Foci Formation in
Response to Replication Stress
Because RAD51 is the pivotal player in replication restart (Hashi-
moto et al., 2010, 2011; Petermann et al., 2010; Schlacher et al.,
2012), we next investigated the impact of CST deficiency on
RAD51 behavior in response to replication stress. We found
that HU-induced RAD51 foci formation was drastically reduced
after knocking down STN1, CTC1, or TEN1 (Figures 6A and
6B). Western blotting showed that RAD51 expression was unal-
tered by STN1 depletion in either unstressed or HU-treated
samples (Figure 6C), excluding the possibility that the reduced
RAD51 foci formation was caused by decreased protein expres-
sion. Due to the unavailability of high-quality TEN1 and CTC1 an-
tibodies, western blotting was not performed in TEN1 and CTC1
knockdown cells.
CST Deficiency Impairs RAD51 Recruitment to
Telomeres and FSs in Response to Replication Stress
The decreased RAD51 foci formation led us to hypothesize that
CST might be important for recruiting RAD51 to fragile se-
quences upon fork stalling. To test this, we performed ChIP
and examined whether STN1 deficiency affected RAD51 recruit-
ment to telomeres and ChIP-seq identified fragile sequences.
Consistent with previous reports (Badie et al., 2010; Verdun
and Karlseder, 2006), we observed RAD51 binding to telomeresnces.
HU-12 inmetaphase cells after HU treatment. FISHprobes are in red. Locations
d bars above the images. Different types of fragilities are indicated by arrows.
ws, elongated signals; orange arrows, signals on two sister chromatids con-
lly separated from the chromosome.
-treated cells. Two non-STN1-binding sites, actin and SLITRK6, were used as
r of chromatids analyzed in each sample.
own cells after HU exposure.
denotes the number of total metaphase spreads measured in each sample.
ance.
Figure 4. CST Proteins Colocalize with RAD51 after Fork Stalling
(A–I) Asynchronized HeLa-FLAG-STN1, HeLa-FLAG-TEN1, or HeLa-Myc-CTC1 cells were treated with 2 mMHU overnight, fixed, and stained with the indicated
antibodies.
(A, D, and G) Colocalization of FLAG-STN1, HA-TEN1, and Myc-CTC1 with RAD51 after HU treatment.
(B, E, and H) Percentage of cells containing more than five CST proteins and RAD51 colocalizations. Binomial z statistic pairwise comparison was used for
statistical analysis.
(C, F, and I) Mean number of CST/RAD51 colocalizations per cell. Two-tailed t tests were used for statistical analysis.
Error bars, SEM.without HU treatment (Figures 7A and 7B). As expected, RAD51
loading to telomeres was increased upon HU treatment (Figures
7A and 7B), presumably because additional RAD51 was re-
cruited to telomeres for restarting stalled replication. RAD51
recruitment to telomeres was significantly reduced by STN1 defi-ciency in both untreated and HU-treated cells (Figures 7A and
7B). Complementing RNAi-resistant STN1 cDNA resulted in
near-complete rescue of RAD51 binding under both untreated
andHU-treated conditions (Figures 7C and 7D, noHU; Figure 7E,
with HU), indicating that the decreased RAD51 binding wasCell Reports 16, 1300–1314, August 2, 2016 1307
specific to STN1 knockdown. We also found that STN1 defi-
ciency diminished RAD51 binding to telomeres in a different
cell line, U2OS (Figure S7), implying that the effect of STN1 defi-
ciency on RAD51 telomeric recruitment is not cell line specific.
Next, we tested whether RAD51 recruitment to non-telomeric
fragile sequences was affected by STN1 deficiency. qPCR was
performed following RAD51 ChIP on six representative STN1-
binding sequences identified from ChIP-seq (HU-7, HU-8, HU-
10, HU-12, HU-13, and HU-21). Again, we observed a marked
increase of RAD51 binding to these sequences upon HU treat-
ment (Figure 7F), in agreement with our conclusion from cytoge-
netic analysis that STN1-binding sequences were FSs (Figure 3).
In contrast, non-STN1-binding sites such as actin, tubulin, and
SLITRK6 sequences showed undetectable RAD51 binding (Fig-
ure 7F). STN1 deficiency resulted in a significant reduction in
RAD51 binding to all six tested fragile sequences after HU treat-
ment (Figure 7F). Altogether, our results support that CST facili-
tates RAD51 recruitment to GC-rich repetitive FSs genome-wide
in response to HU-induced replication stress and dysfunctional
CST impairs the recruitment of RAD51 to these sites, resulting
in inefficient replication restart (Figure 7G).
DISCUSSION
Restart of stalled replication requires the assembly of multiple
proteins at stalled sites, and their synergistic actions are needed
to stabilize stalled forks and to ensure successful reinitiation of
DNA synthesis (Sirbu et al., 2013). The CST complex has been
shown to be important for reinitiating stalled DNA synthesis at
both telomeric and non-telomeric sequences (Gu et al., 2012;
Huang et al., 2012; Stewart et al., 2012; Wang et al., 2014).
Although it has been proposed that CST promotes origin firing
upon fork stalling (Stewart et al., 2012), the molecular mecha-
nism underlying CST-mediated replication reinitiating is largely
unclear. It is unknown how CST fits into the overall picture of
replication restart and how the complex interplays with other
replication restart factors. In this study, we map STN1-binding
sites with ChIP-seq and find that STN1 is frequently enriched
at GC-rich repetitive sequences after HU exposure. Representa-
tive STN1-binding sequences display fragility upon HU expo-
sure, suggesting that these sequences are bona fide FSs.
Fragility is exacerbated by STN1 deficiency, resulting in chromo-
some fragmentation. Thus, we provide the first line of evidence
that functional CST is required for protecting the stability of these
fragile loci in response to perturbed replication.
To date,mostmapped FSs have been induced by low concen-
trations of the DNA polymerase inhibitor APH. These CFSs are
usually AT-rich, transcriptionally repressed, and late replicating
(Debatisse et al., 2012). Studies suggest that sequences sharing
no obvious features with CFSs can also become sensitive to
replication stress. For instance, oncogene expression induces
an FS landscape that only partially overlaps with APH-induced
CFSs (Miron et al., 2015). InmouseB lymphocytes, HU treatment
induces a group of FSs termed ERFSs that are in general GC-
rich, transcriptionally active, and located at CpG islands. These
regions are associated with chromosome breakages and aber-
rant rearrangements (Barlow et al., 2013). Most STN1-binding
sites reside outside putative CFSs (Figure S5), with sequence1308 Cell Reports 16, 1300–1314, August 2, 2016features being similar to ERFSs. Therefore, our study adds to
the growing evidence for the complexity and diversity of FSs in
the human and mammalian genome.
Upon fork stalling, ssDNA accumulates at stalled sites due to
uncoupling of DNA unwinding and DNA synthesis. Failure to pro-
tect ssDNA leads tonucleolytic attack, compromising the integrity
of nascentDNAat stalled forks and resulting in increasedchromo-
somal aberrations in human precancerous lesions. Proteins bind-
ing to ssDNA have multiple roles in protecting ssDNA, mediating
protein-protein interactions, and stimulating strand-exchange
proteins and helicases (Richard et al., 2009). It has been shown
that prompt restart of stalled replication relies on the ssDNA-bind-
ing protein RAD51. RAD51 protects nascent DNA from nuclease
degradation at stalled forks (Hashimoto et al., 2010) andmediates
two pathways for restarting stalled forks by facilitating new origin
firing and/or by homologous recombination (Petermann et al.,
2010). One report suggests that CST facilitates the restart of
stalled replication through promoting origin firing (Stewart et al.,
2012), but the underlying mechanism for such promotion is un-
known. In this study, we provide evidence that in response to
HU treatment, components of CST form distinct foci that colocal-
ize with RAD51 and physically interact with RAD51 (Figures 4
and 5). We further show that CST deficiency significantly dimin-
ishes HU-induced RAD51 foci formation and reduces RAD51
recruitment to telomeres and non-telomeric fragile sequences un-
der replication stress (Figures 6 and 7).We propose that CSTmay
be particularly important for efficient RAD51 recruitment to these
GC-rich repetitive sequences upon fork stalling (Figure 7G).
Because single-stranded G-rich repetitive sequences, including
telomeric repeats, are prone to forming secondary structures
like G-quadruplexes, it is tempting to speculate that CST may
bind toG-rich repetitive ssDNAanddisfavorG-quadruplex forma-
tion, allowing efficient binding of RAD51 to ssDNA for replication
restart. It is also possible that binding of CST to ssDNAmay assist
in recruiting helicases and/or stimulate helicase unwinding of
G-quadruplexes. Alternatively, CST deficiency may disrupt the
chromatin structure favoring RAD51 recruitment and nucleofila-
ment formation, resulting in reduced RAD51 binding to ssDNA
at stalled sites. Nonetheless, our findings provide novel mecha-
nistic insights into how CST promotes replication restart, which
is important for understanding how genome stability is protected
under replication stress.
Results in this study do not exclude the possibility that CST
may use RAD51-independent pathways to facilitate replication
restart. In fact, a subset of CST protein foci did not share coloc-
alization with RAD51 after HU treatment (Figure 4). It will be
interesting to examine the relationship of CST with other replica-
tion restart proteins, which will provide needed insights into
RAD51-independent pathways in which CST may be involved.
The CST complex interacts with POLa and is able to stimulate
the priming activity of POLa and primase-to-polymerase switch-
ing (Casteel et al., 2009; Lue et al., 2014; Nakaoka et al., 2012).
POLa is an important replisome component at active replication
forks and necessary for Okazaki fragment synthesis. It could be
argued that its primase or polymerase activity might be used to
reinitiate DNA synthesis during replication start. However, prote-
omics study fails to identify the enrichment of POLa subunits at
stalled replication forks (Sirbu et al., 2013). Mammalian cells
Figure 5. CST Proteins Physically Interact with RAD51 under Replication Stress in an ATR-Dependent Manner
(A) HeLa-Myc-STN1 cells were treated with 2 mM HU (left panel) or treated with 0.2 mM APH (right panel) for 20 hr, followed by coIP with anti-myc antibody.
Precipitates were analyzed by western blotting to detect endogenous RAD51 that was pulled down by Myc-STN1.
(B) Reciprocal coIP. IP was performed with HeLa-Myc-STN1 cells with anti-RAD51 antibody, followed by western blotting to detect Myc-STN1 pulled down by
RAD51.
(legend continued on next page)
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Figure 6. Deficiency in CST Reduces RAD51 Foci Formation after HU Treatment
(A) HU-induced RAD51 foci formation was significantly decreased after CTC1, STN1, or TEN1 knockdown. HeLa cells stably expressing shLuc, shCTC1, shSTN1,
or shTEN1 were treated with 2 mM HU for overnight and then fixed for RAD51 immunofluorescent staining (red).
(B) Quantification of relative RAD51 foci intensity in CST knockdown cells. ***p% 0.001.
(C) RAD51 expression detected by western blotting in the presence or absence of HU in STN1 knockdown cells.encode a different primase, PrimPol, which displays both pri-
mase and polymerase activities (Garcı´a-Go´mez et al., 2013).
PrimPol is able to reprime DNA synthesis at forks stalled by
HU or UV irradiation and facilitate fork progression (Bianchi
et al., 2013; Mouro´n et al., 2013), raising the question of whether
POLa is an active component in fork rescue. Thus, it remains(C) STN1/RAD51 interaction is independent of DNA. Whole-cell lysates were treat
performed with anti-myc antibody and precipitates were analyzed by anti-RAD51
untreated lysates was purified by phenol extraction, separated on agarose, and st
removal of DNA by DNase I treatment.
(D–F) CTC1 and TEN1 physically interact with endogenous RAD51 under repl
HEK293T cells and treated with 2 mM HU or 0.2 mM APH for 20 hr, followed by r
(D) IP was performed with anti-RAD51 recognizing endogenous RAD51, followe
munoprecipitates.
(E) IP was performed with anti-FLAG, followed by western blotting to detect RAD
the RAD51 band.
(F) IP was performed with anti-HA, followed by western blotting to detect RAD51
(G) CST/RAD51 interaction is dependent on ATR activity. FLAG-CTC1, Myc-STN1
or 0.2 mM APH in the presence or absence of ATR inhibitor (ATRi) for 20 hr. IP w
western blotting to detect FLAG-CTC1, Myc-STN1, and HA-TEN1 in immunopre
1310 Cell Reports 16, 1300–1314, August 2, 2016a subject of debate whether the enhancing effect of CST on
POLa activity plays a significant role in rescuing stalled replica-
tion. However, it seems that CST/POLa interaction may be
important for telomere maintenance. CTC1 mutations that
abolish POLa interaction show reduced telomere association,
accompanied by a telomere replication defect, suggesting thated with DNase I or untreated before IP. Following DNase I treatment, coIP was
western blotting to detect RAD51 that was pulled down. DNA from treated and
ained with ethidium bromide. The agarose gel image (bottom panel) shows the
ication stress. FLAG-CTC1, Myc-STN1, and HA-TEN1 were coexpressed in
eciprocal coIP.
d by western blotting to detect FLAG-CTC1, Myc-STN1, and HA-TEN1 in im-
51, Myc-STN1, and HA-TEN1 in the immunoprecipitates. An asterisk indicates
in the immunoprecipitates.
, and HA-TEN1 were coexpressed in HEK293T cells and treated with 2 mMHU
as performed with anti-RAD51 recognizing endogenous RAD51, followed by
cipitates.
A B
C
D E G
F
Figure 7. STN1 Deficiency Diminishes RAD51 Recruitment to Telomeres and STN1-Binding Sites upon Replication Stalling
(A) Representative slot blot of RAD51 ChIP at telomeres in STN1-deficient cells. HeLa cells expressing shLuc or shSTN1 were treated with HU (2 mM) or un-
treated, followed by crosslinking and ChIP. ChIP DNA was loaded on slot blot and hybridized to telomere probe.
(B) Quantitation of RAD51 binding to telomeric DNA. Results are represented as percentage of input. The p valueswere calculated with two-tailed t test from three
independent experiments.
(C) The effect of STN1 deficiency on RAD51 binding to telomeric DNA is specific. RNAi-resistant STN1 (r-STN1) was expressed in STN1 knockdown cells, treated
with HU or untreated, and crosslinked, and ChIP was performed. Representative slot blot of RAD51 ChIP at telomeres is shown.
(D and E) Quantitation of RAD51 binding to telomeric DNA without HU (D) and with HU (E). The p values were calculated with two-tailed t test from three in-
dependent experiments.
(F) STN1 deficiency reduced RAD51 recruitment to FSs after HU treatment. Quantitation of RAD51 recruitment to representative STN1-binding sites from ChIP in
STN1-deficient cells and control cells with qPCR. Two-tailed t tests were used to calculate p values from three independent ChIP assays, with qPCR assays being
performed in duplicates in each ChIP experiment. Results are represented as percentage of input. *p < 0.05, **p < 0.01.
(G) Model for CST in promoting replication restart. Upon fork stalling at GC-rich repetitive sequences, ssDNA accumulates. CST binds to ssDNA and recruits
RAD51 to stalled sites. In the absence of CST, the GC-rich repetitive ssDNA at stalled sites may form secondary structures that prevent efficient binding of
RAD51, resulting in fork collapse and genome instability.
Error bars, SEM.
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CST/POLa interaction may facilitate telomeric DNA replication
(Chen et al., 2013). CST stimulation on POLa activity could
also be important for filling the terminal C strand gap that
remains after telomere replication and/or telomerase elongation
(Chen et al., 2013; Huang et al., 2012).
Mutations in CTC1 cause Coats plus, a disease sharing
overlapping pathological phenotypes with the telomere defect
disease known as dyskerotosis congenita (DC) (Anderson
et al., 2012; Keller et al., 2012; Polvi et al., 2012). Because a
subset of Coats plus patients show markedly shortened telo-
meres (Anderson et al., 2012), Coats plus has been considered
a telomere maintenance disorder, and the pathogenesis of
Coats plus may partly derive from telomere defects (Savage,
2012). However, a few pathological CTC1 mutations display
no obvious telomere maintenance defects (Polvi et al., 2012).
Moreover, CST binds to ssDNA in a sequence-independent
manner, and Coats plus patients display neurological manifes-
tations distinct from DC. These observations suggest that the
pathogenesis of Coats plus may also be related to non-telo-
meric CTC1 dysfunction. Our findings that CST is important
for maintaining the stability of non-telomeric GC-rich repetitive
sequences potentiates the role of FS instabilities in Coats plus
disease development. Further studies will be needed to test
this possibility and to determine whether pathological CTC1
mutations induce FS instability in the genome. Results will
allow for a more accurate understanding of the pathogenesis
of Coats plus and aid in designing more effective therapeutic
approaches.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in Supplemental Information.
Cell culture, shRNA, ChIP-seq, qPCR, and immunofluorescence (IF) were
performed using standard protocols. FISH on metaphase chromosomes,
ChIP-seq analysis, and qPCR quantification are described in detail in Supple-
mental Information.
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